Sales and Marketing

Showing 15 posts of 11524 posts found.

merck_incweb

MSD scores EU approval for Keytruda in lung cancer

August 3, 2016 Research and Development, Sales and Marketing EU, MSD, Merck, approval, keytruda, lung cancer

MSD, called Merck in the US and Canada, has announced that the European Commission has approved Keytruda (pembrolizumab) for patients …
novartis_building

Breakthrough therapy designation for Novartis in advanced breast cancer treatment

August 3, 2016 Research and Development, Sales and Marketing Breakthrough Therapy Designation, FDA, LEE011, Novartis, ribociclib

Novartis has announced that the US Food and Drug Administration (FDA) has granted a breakthrough therapy designation to LEE011 (ribociclib) …
shire_image

Shire Q2 results outpace forecasts with 56% revenue growth

August 2, 2016 Research and Development, Sales and Marketing Baxalta, Shire, financial report

Shire has announced its fiscal results for Q2 2016, reporting a strong quarter with a 56% growth in total revenues …
pfizer_reflection

Revenue rises at Pfizer as Ibrance and Xeljanz beat sales expectations

August 2, 2016 Research and Development, Sales and Marketing 2016, Pfizer, Prevnar, Q2, Xeljanz, ibrance, results

Pfizer has published its Q2 results, which show revenues rising 11% with new drugs helping to drive the growth and …

Landmark UK ruling as judge rules PrEP can be funded on NHS

August 2, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Judge, NHS, PrEP, UK, available, ruling

A London high court judge has ruled in favour of a challenge brought by the National Aids Trust to allow …

Joint Article on Hydrogen Peroxide Efficacy Published in Letters in Applied Microbiology

August 2, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wickham laboratories

Wickham Laboratories Ltd is pleased to announce the publication of a joint study with Bioquell on the efficacy of disinfection …
eisa0002

Evaluation of Eisai’s advanced thyroid cancer treatment blocked until 2018 in England

August 2, 2016 Manufacturing and Production, Sales and Marketing CDF, Eisai, Lenvima, NHS, NICE, lenvatinib, thyroid cancer

Following negotiations between the NHS, NICE and Japanese pharmaceutical company Eisai, differentiated thyroid cancer (RAI-R DTC) drug lenvima (levatinib) has …

Sartorius doubles production capacity in UK with new facility

August 1, 2016 Manufacturing and Production, Sales and Marketing Princess Anne, Sartorius, UK, expansion

Pharmaceutical and laboratory equipment provider Sartorius has expanded operations at its Stonehouse site in Gloucestershire with a new plant, doubling …
merck_and_co

European Commission approves Zepatier for chronic hepatitis C infection

August 1, 2016 Research and Development, Sales and Marketing

MSD, known as Merck in the US and Canada, has announced that the European Commission has approved Zepatier (elbasvir/grazoprevir) with …

Surprise for Seres as shares sent tumbling by Phase II failure

August 1, 2016 Research and Development, Sales and Marketing FDA, clostrodium difficile, seres therapeutics

Seres Therapeutics has presented interim results from an ongoing Phase II trial which has sent company stock spiralling downward, as …
a_scientist_at_work_at_sanofis_immunology_laboratory_in_thailand

EMA accepts MMA for rheumatoid arthritis treatment Sarilumab

August 1, 2016 Research and Development, Sales and Marketing EMA, MAA, Regeneron, Sanofi, sarilumab

Sanofi and Regeneron Pharmaceuticals have announced that the European Medicines Agency (EMA) has accepted the Marketing Authorisation Application (MAA) for …
GSK image

GSK and Alphabet to create bioelectronics medicines in £540 million partnership

August 1, 2016 Research and Development, Sales and Marketing Alphabet, GSK, Verily, bioelectronic medicine, galvani, google

GlaxoSmithKline and Verily Life Sciences, a division of Google’s parent company Alphabet, have announced a £540 million partnership that will …
humacao_exterior

Bristol-Myers Squibb grows revenues 17% to $4.9 billion in Q2 2016

July 29, 2016 Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, finance, opdivo

Bristol-Myers Squibb has announced its financial results for the second quarter of 2016, noting sizeable year-on-year sales growth and leaps …

China’s Fosun seals $1.3 billion deal for Gland Pharma

July 29, 2016 Medical Communications, Sales and Marketing acquisition, fosun, gland, takeover

Fosun Pharmaceutical has agreed a deal to purchase an 86.1% stake of Gland Pharma, which will see the Chinese firm …
The Gateway to Local Adoption Series

Latest content